Endocrinology News and Research

Latest Endocrinology News and Research

Stem cell therapies for heart disease - one step closer

New research from the University of Bristol brings stem cell therapies for heart disease one step closer. The findings reveal that our bodies' ability to respond to an internal 'mayday' signal may hold the key to success for long-awaited regenerative medicine.

30 Oct 2008

Melanin shows potential as new drug target for obesity

As millions of Americans gear up for the Thanksgiving holiday, a new research report published online in The FASEB Journal, may provide some relief for those leery of having a second helping.

29 Oct 2008

Drinking milk to ease milk allergy?

Giving children with milk allergies increasingly higher doses of milk over time may ease, and even help them completely overcome, their allergic reactions, according to the results of a study led by the Johns Hopkins Children's Center and conducted jointly with Duke University.

29 Oct 2008

Protein in urine could be a predictor of heart disease

Scientists at the George Institute for International Health say urine tests should be incorporated into analysing heart disease risk.

29 Oct 2008

Malaria medication hydroxychloroquine prevents diabetes in arthritis patients

The use of an antimalarial medication may prevent the onset of diabetes in patients with rheumatoid arthritis, new Geisinger research shows.

28 Oct 2008

New signpost to clinical trial expertise

A new comprehensive online resource listing national expertise in the design and conduct of clinical trials is launched today. The UKCRC Registered Clinical Trials Units website provides, for the first time, centralised information on Clinical Trials Units (CTUs) in the UK - including the Bristol Randomised Trials Collaboration (BRTC) at the University of Bristol.

28 Oct 2008

Selenium and vitamin E supplements do not prevent prostate cancer

Initial, independent review of study data from the Selenium and Vitamin E Cancer Prevention Trial (SELECT), funded by the National Cancer Institute (NCI) and other institutes that comprise the National Institutes of Health shows that selenium and vitamin E supplements, taken either alone or together, did not prevent prostate cancer.

28 Oct 2008

Vitamin E and selenium do not prevent prostate cancer

A major study on whether vitamin E and selenium prevent prostate cancer has been stopped because the supplements are not effective and also because there is a suspicion of a risk.

28 Oct 2008

Expensive new diabetes drugs don't necessarily produce better outcomes

The annual cost of prescription diabetes drugs nearly doubled to $12.5 billion between 2001 and 2007, according to a study by researchers at the Stanford University School of Medicine and the University of Chicago. The researchers say the findings raise questions about whether the higher cost actually translates into improved care and better outcomes.

28 Oct 2008

Lots of neighborhood greenness linked to lower children's body mass

In the first study to look at the effect of neighborhood greenness on inner city children's weight over time, researchers from the Indiana University School of Medicine, Indiana University-Purdue University Indianapolis and the University of Washington report that higher neighborhood greenness is associated with slower increases in children's body mass over a two year period, regardless of residential density.

28 Oct 2008

Discovery of new gene responsible for puberty disorders

A new gene responsible for some puberty disorders has been identified by Medical College of Georgia researchers.

27 Oct 2008

Eating whole grains lowers heart failure risk

About 5 million people in the United States suffer from heart failure (HF). While some reports indicate that changes to diet can reduce HF risk, few large, prospective studies have been conducted.

27 Oct 2008

Purple tomatoes the latest in the arsenal against cancer

British scientists have developed purple tomatoes which they believe may possibly help fight cancer.

27 Oct 2008

First-ever international guidelines for the treatment of psoriatic arthritis

Rheumatologists, dermatologists, and patient advocates have come together to publish the first-ever international guidelines for the treatment of psoriatic arthritis, a disease that mainly affects people who have psoriasis but also some people without it.

26 Oct 2008

Life in Canada more deadly for immigrants?

Immigrants who come to Canada seeking a better life may in fact be setting themselves up for possible premature death.

26 Oct 2008

Advancing medical research

Researchers from the University of Essex and medical counterparts from Colchester Hospital University NHS Foundation Trust are working together to develop successful partnerships in advancing medical research.

26 Oct 2008

Research targets diabetes-related eye conditions

World Diabetes Day is on 14 November this year highlighting that diabetes is on the increase and to create awareness to aid prevention of figures growing larger. To help prevent diabetes becoming a burden to the NHS resources in the future, new research projects commissioned by the National Institute for Health Research's Health Technology Assessment (NIHR HTA) programme will evaluate the effectiveness and cost-effectiveness of different screening tests used in diabetic eye care.

23 Oct 2008

Exposure to low doses of mercury changes the way the arteries work

An international team of researchers has shown that mercury is another important factor in cardiovascular disease as it changes the way arteries work. One of the possible sources of exposure of humans to mercury is by eating contaminated fish.

23 Oct 2008

Leukaemia drug may reverse multiple sclerosis brain damage

Scientists in Britain say a drug which was developed to treat leukaemia may also be a powerful new weapon against multiple sclerosis (MS).

23 Oct 2008

New obesity drug Tesofensine may have huge potential

According to trials, a new obesity drug, Tesofensine, which may be launched on the world market in a few years, can produce weight loss twice that of currently approved obesity drugs. The Danish company Neurosearch and a number of researchers at the Faculty of Life Sciences at University of Copenhagen are behind the promising findings.

23 Oct 2008